• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

新冠病毒病患者中头孢吡肟诱导的脑病:病例报告。

Cefepime-induced encephalopathy in a COVID-19 patient: a case report.

机构信息

Department of Anesthesiology and Critical Care Medicine, Fujita Health University, Toyoake, Japan.

Department of Anesthesiology and Intensive Care Medicine, Nishichita General Hospital, 3-1-1, Nakanoike, Tokai, Aichi, 477-8522, Japan.

出版信息

J Anesth. 2022 Jun;36(3):432-435. doi: 10.1007/s00540-022-03068-1. Epub 2022 Apr 29.

DOI:10.1007/s00540-022-03068-1
PMID:35487992
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9053838/
Abstract

Prolonged neurological symptoms such as "brain fog" and cognitive impairment have occurred after coronavirus disease 2019 (COVID-19) infection. In this report, we describe impaired consciousness caused by cefepime hydrochloride (CFPM) in a patient with cognitive sequalae of COVID-19. A 56-year-old male patient was diagnosed with penile abscess after COVID-19 infection, and a blood culture detected two drug-resistant Pseudomonas aeruginosa strains. Therefore, CFPM 2 g × twice/day was administered on day 71 after intensive care unit admission. Approximately 48 h after CFPM administration, the patient showed disturbances in consciousness. Contrast-enhanced computed tomography, magnetic resonance imaging, and spinal fluid examination revealed no obvious abnormalities. Therefore, CFPM-induced neurotoxicity was suspected. CFPM was discontinued and ceftazidime 2 g × three times/day was initiated. The patient's consciousness improved 30 h after the final administration of CFPM. Serum CFPM concentrations were 14.2, 21.7, 21.7, and 11.9 μg/mL on days 1, 2, and 3 after the initiation of CFPM and on the day after CFPM was discontinued, respectively. In conclusion, intensivists should pay attention to new neurological symptoms such as CFPM-induced encephalopathy in patients with prolonged neurological symptoms after COVID-19 infection.

摘要

新冠病毒病(COVID-19)感染后可出现长期神经症状,如“脑雾”和认知障碍。在此报告中,我们描述了 COVID-19 认知后遗症患者因注射盐酸头孢吡肟(CFPM)而导致意识障碍的病例。一名 56 岁男性患者在 COVID-19 感染后被诊断为阴茎脓肿,血培养检出两株耐多药铜绿假单胞菌。因此,在入住重症监护病房后第 71 天给予 CFPM 2 g,一日两次。在 CFPM 给药后约 48 h,患者出现意识障碍。增强 CT、磁共振成像和脑脊液检查均未见明显异常。因此,疑似 CFPM 诱导的神经毒性。停用 CFPM 并开始给予头孢他啶 2 g,一日三次。在 CFPM 末次给药后 30 h,患者意识改善。CFPM 起始后第 1、2、3 天及第 1 天 CFPM 停药后,血清 CFPM 浓度分别为 14.2、21.7、21.7 和 11.9 μg/mL。总之,对于 COVID-19 感染后长期出现神经症状的患者,重症监护医生应注意 CFPM 引起的脑病等新的神经症状。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/265c/9053838/4fa787e7fae7/540_2022_3068_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/265c/9053838/4fa787e7fae7/540_2022_3068_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/265c/9053838/4fa787e7fae7/540_2022_3068_Fig1_HTML.jpg

相似文献

1
Cefepime-induced encephalopathy in a COVID-19 patient: a case report.新冠病毒病患者中头孢吡肟诱导的脑病:病例报告。
J Anesth. 2022 Jun;36(3):432-435. doi: 10.1007/s00540-022-03068-1. Epub 2022 Apr 29.
2
Cefepime-induced encephalopathy in end-stage renal disease patients.终末期肾病患者中头孢吡肟诱发的脑病
J Neurol Sci. 2017 May 15;376:123-128. doi: 10.1016/j.jns.2017.03.018. Epub 2017 Mar 16.
3
[Severely abnormal electroencephalogram in two patients who were treated with cefepime].[两名接受头孢吡肟治疗的患者出现严重异常脑电图]
Rinsho Shinkeigaku. 2012;52(5):356-9. doi: 10.5692/clinicalneurol.52.356.
4
[Dose finding study of cefepime for chronic respiratory infections].[头孢吡肟用于慢性呼吸道感染的剂量探索研究]
Kansenshogaku Zasshi. 1992 Jul;66(7):837-58. doi: 10.11150/kansenshogakuzasshi1970.66.837.
5
[A comparative study of cefepime for chronic respiratory tract infections].头孢吡肟用于慢性呼吸道感染的对比研究
Kansenshogaku Zasshi. 1992 Jul;66(7):886-908. doi: 10.11150/kansenshogakuzasshi1970.66.886.
6
Cefepime Neurotoxicity in Patients With Normal Renal Function: An Overlooked Cause of Encephalopathy in the Intensive Care Unit.肾功能正常患者的头孢吡肟神经毒性:重症监护病房脑病的一个被忽视原因。
J Investig Med High Impact Case Rep. 2024 Jan-Dec;12:23247096241259534. doi: 10.1177/23247096241259534.
7
[A case of Cefepime encephalopathy, being difficult to distinguish from non-convulsive status epilepticus during the treatment of bacterial meningitis].[1例头孢吡肟脑病,在细菌性脑膜炎治疗期间难以与非惊厥性癫痫持续状态相鉴别]
Rinsho Shinkeigaku. 2016 Oct 28;56(10):678-683. doi: 10.5692/clinicalneurol.cn-000898.
8
[A comparative study of cefepime for bacterial pneumonia].头孢吡肟用于细菌性肺炎的比较研究
Kansenshogaku Zasshi. 1992 Jul;66(7):859-85. doi: 10.11150/kansenshogakuzasshi1970.66.859.
9
Cefepime Induced Encephalopathy in a Non-dialysis Dependent Chronic Kidney Disease Patient: A Case Report.头孢吡肟致非透析依赖慢性肾脏病患者脑病:一例报告。
Acta Med Indones. 2023 Jan;55(1):78-82.
10
Cefepime-related encephalopathy in peritoneal dialysis patients.腹膜透析患者的头孢吡肟相关性脑病。
J Chin Med Assoc. 2011 Feb;74(2):87-90. doi: 10.1016/j.jcma.2011.01.017.

引用本文的文献

1
The Trend of Cefepime-Induced Neurotoxicity: A Systematic Review.头孢吡肟所致神经毒性的趋势:一项系统评价
Cureus. 2023 Jun 26;15(6):e40980. doi: 10.7759/cureus.40980. eCollection 2023 Jun.

本文引用的文献

1
Cognitive decline and brainstem hypometabolism in long COVID: A case series.长新冠患者的认知能力下降和脑干代谢低下:病例系列研究。
Brain Behav. 2022 Apr;12(4):e2513. doi: 10.1002/brb3.2513. Epub 2022 Mar 15.
2
Neurological manifestations of long-COVID syndrome: a narrative review.新冠后综合征的神经学表现:一项叙述性综述
Ther Adv Chronic Dis. 2022 Feb 17;13:20406223221076890. doi: 10.1177/20406223221076890. eCollection 2022.
3
Neurological complications associated with Covid-19; molecular mechanisms and therapeutic approaches.
与新冠病毒相关的神经系统并发症;分子机制与治疗方法。
Rev Med Virol. 2022 Nov;32(6):e2334. doi: 10.1002/rmv.2334. Epub 2022 Feb 9.
4
Rocuronium-Induced Dilated Nonreactive Pupils in a Patient With Coronavirus Disease 2019: A Case Report.1例2019冠状病毒病患者中罗库溴铵诱导的瞳孔散大且无反应:病例报告
A A Pract. 2021 Jun 24;15(7):e01491. doi: 10.1213/XAA.0000000000001491.
5
COVID-19-Associated Neurological Disorders: The Potential Route of CNS Invasion and Blood-Brain Relevance.COVID-19 相关神经系统疾病:CNS 入侵和血脑相关性的潜在途径。
Cells. 2020 Oct 27;9(11):2360. doi: 10.3390/cells9112360.
6
Neuroinvasion, neurotropic, and neuroinflammatory events of SARS-CoV-2: understanding the neurological manifestations in COVID-19 patients.SARS-CoV-2 的神经入侵、嗜神经性和神经炎症事件:了解 COVID-19 患者的神经表现。
Neurol Sci. 2020 Oct;41(10):2657-2669. doi: 10.1007/s10072-020-04575-3. Epub 2020 Jul 28.
7
COVID-19-related acute necrotizing encephalopathy with brain stem involvement in a patient with aplastic anemia.COVID-19 相关急性坏死性脑病伴再生障碍性贫血患者脑干受累。
Neurol Neuroimmunol Neuroinflamm. 2020 May 26;7(5). doi: 10.1212/NXI.0000000000000789. Print 2020 Sep 3.
8
SARS-CoV-2 can induce brain and spine demyelinating lesions.严重急性呼吸综合征冠状病毒2(SARS-CoV-2)可诱发脑和脊髓脱髓鞘病变。
Acta Neurochir (Wien). 2020 Jul;162(7):1491-1494. doi: 10.1007/s00701-020-04374-x. Epub 2020 May 4.
9
Miller Fisher syndrome and polyneuritis cranialis in COVID-19.COVID-19 相关米勒费希尔综合征和颅神经病。
Neurology. 2020 Aug 4;95(5):e601-e605. doi: 10.1212/WNL.0000000000009619. Epub 2020 Apr 17.
10
Neurologic Features in Severe SARS-CoV-2 Infection.严重SARS-CoV-2感染的神经系统特征
N Engl J Med. 2020 Jun 4;382(23):2268-2270. doi: 10.1056/NEJMc2008597. Epub 2020 Apr 15.